These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 29516307)

  • 1. Transition of Left Ventricular Ejection Fraction in Heart Failure.
    Sakata Y; Tsuji K; Nochioka K; Shimokawa H
    Adv Exp Med Biol; 2018; 1067():5-15. PubMed ID: 29516307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure with recovered ejection fraction: Clinical characteristics, determinants and prognosis. CARDIOCHUS-CHOP registry.
    Agra Bermejo R; Gonzalez Babarro E; López Canoa JN; Varela Román A; Gómez Otero I; Oro Ayude M; Parada Vazquez P; Gómez Rodríguez I; Díaz Castro O; González Juanatey JR
    Cardiol J; 2018; 25(3):353-362. PubMed ID: 28980289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study.
    Tsuji K; Sakata Y; Nochioka K; Miura M; Yamauchi T; Onose T; Abe R; Oikawa T; Kasahara S; Sato M; Shiroto T; Takahashi J; Miyata S; Shimokawa H;
    Eur J Heart Fail; 2017 Oct; 19(10):1258-1269. PubMed ID: 28370829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular ejection fraction as therapeutic target: is it the ideal marker?
    Katsi V; Georgiopoulos G; Laina A; Koutli E; Parissis J; Tsioufis C; Nihoyannopoulos P; Tousoulis D
    Heart Fail Rev; 2017 Nov; 22(6):641-655. PubMed ID: 28601914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and prognosis of patients admitted for heart failure: A 5-year retrospective study of African patients.
    Bonsu KO; Owusu IK; Buabeng KO; Reidpath DD; Kadirvelu A
    Int J Cardiol; 2017 Jul; 238():128-135. PubMed ID: 28318656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.
    Maeder MT; Kaye DM
    Int J Cardiol; 2012 Mar; 155(2):249-56. PubMed ID: 21035207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis.
    Ma C; Luo H; Fan L; Liu X; Gao C
    Braz J Med Biol Res; 2020; 53(7):e9646. PubMed ID: 32520204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left Ventricular Ejection Fraction (EF) of 55% as Cutoff for Late Transition From Heart Failure (HF) With Preserved EF to HF With Mildly Reduced EF.
    Ueda T; Kawakami R; Nishida T; Onoue K; Soeda T; Okayama S; Takeda Y; Watanabe M; Kawata H; Uemura S; Saito Y
    Circ J; 2015; 79(10):2209-15. PubMed ID: 26227392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short and long-term prognostic value of hyponatremia in heart failure with preserved ejection fraction versus reduced ejection fraction: An analysis of the Korean Acute Heart Failure registry.
    Park JJ; Cho YJ; Oh IY; Park HA; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    Int J Cardiol; 2017 Dec; 248():239-245. PubMed ID: 28821416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants and Prognostic Impact of Heart Failure and Left Ventricular Ejection Fraction in Acute Coronary Syndrome Settings.
    Agra Bermejo R; Cordero A; García-Acuña JM; Gómez Otero I; Varela Román A; Martínez Á; Álvarez Rodríguez L; Abou-Jokh C; Rodríguez-Mañero M; Cid Álvarez B; López-Palop R; Carrillo P; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2018 Oct; 71(10):820-828. PubMed ID: 29249471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart Failure With Preserved Ejection Fraction.
    Reddy YN; Borlaug BA
    Curr Probl Cardiol; 2016 Apr; 41(4):145-88. PubMed ID: 26952248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure with preserved vs reduced ejection fraction following cardiac rehabilitation: impact of endothelial function.
    Tanaka S; Sanuki Y; Ozumi K; Harada T; Tasaki H
    Heart Vessels; 2018 Aug; 33(8):886-892. PubMed ID: 29392470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
    Sanders-van Wijk S; van Empel V; Davarzani N; Maeder MT; Handschin R; Pfisterer ME; Brunner-La Rocca HP;
    Eur J Heart Fail; 2015 Oct; 17(10):1006-14. PubMed ID: 26472682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study.
    Khalid U; Wruck LM; Quibrera PM; Bozkurt B; Nambi V; Virani SS; Jneid H; Agarwal S; Chang PP; Loehr L; Basra SS; Rosamond W; Ballantyne CM; Deswal A
    Int J Cardiol; 2017 Apr; 233():61-66. PubMed ID: 28185703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs.
    Chen YT; Wong LL; Liew OW; Richards AM
    Cells; 2019 Dec; 8(12):. PubMed ID: 31888288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction.
    Rastogi A; Novak E; Platts AE; Mann DL
    Eur J Heart Fail; 2017 Dec; 19(12):1597-1605. PubMed ID: 29024350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure with preserved ejection fraction: Classification based upon phenotype is essential for diagnosis and treatment.
    Xanthopoulos A; Triposkiadis F; Starling RC
    Trends Cardiovasc Med; 2018 Aug; 28(6):392-400. PubMed ID: 29471985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.